Biochemical Specifications

Active Ingredient: Clostridium botulinum toxin type A (Strain CBFC26).

Molecular Weight: 150 kDa (Purified low-diffusion matrix).

Vial Content: 200 Units (±5% batch variance).

Excipients: Sodium Chloride (1.8mg), Sucrose (10mg).

Formulation Base: Albumin-free, Gelatin-free.

Solution pH: 6.8 ± 0.3 (Post-reconstitution).

Clinical Pharmacokinetics

Diffusion Radius: <0.5cm² (High target specificity).

Onset of Action: 48 to 72 hours.

Peak Efficacy: 14 days post-administration.

Therapeutic Duration: 6 to 8 months (in 85% of clinical subjects).

Immunogenicity Risk: <1% antibody formation rate.

Adverse Events: <0.01% localized ptosis or transient erythema.

Diluent: 0.9% sterile, unpreserved Sodium Chloride.

Volume: 5.0 mL per 200U vial.

Concentration: 4.0 Units per 0.1 mL injection volume.

Maximum Dose: 200 Units per patient session. 3-month interval mandatory.

Storage (Unopened): 2°C to 8°C. 36-month shelf life.

Storage (Mixed): 2°C to 8°C. Administer within 24 hours.

Medical Disclaimer & Contraindications